Health News Roundup: Eisai files for approval of Alzheimer’s drug in Japan; WHO says its chief spoke with Chinese officials, welcomes COVID-19 data and more

Following is a abstract of present well being information briefs.
Eisai files for approval of Alzheimer’s drug in Japan
Japanese drugmaker Eisai Co Ltd stated on Monday it had submitted a advertising and marketing authorisation software in Japan for its Alzheimer’s drug lecanemab, which was not too long ago granted accelerated approval in the United States. The drug, developed in partnership with Biogen Inc , is an antibody that has been proven to take away sticky deposits of a protein known as amyloid beta from the brains of these in the early phases of the mind-wasting illness.
WHO says its chief spoke with Chinese officers, welcomes COVID-19 data
The World Health Organization’s head has spoken with Chinese authorities and the company welcomed new details about the state of affairs in the nation, WHO stated on Saturday after Beijing launched new data displaying a giant soar in COVID-19-related deaths. Director General Tedros Adhanom Ghebreyesus spoke with Ma Xiaowei, director of China’s National Health Commission, concerning the wave of infections which erupted after the nation abruptly dismantled its anti-virus regime final month.
U.S. FDA, CDC see early sign of attainable Pfizer bivalent COVID shot hyperlink to stroke
A security monitoring system flagged that U.S. drugmaker Pfizer Inc and German companion BioNTech’s up to date COVID-19 shot could possibly be linked to a kind of mind stroke in older adults, in line with preliminary data analyzed by U.S. well being authorities. The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) stated on Friday {that a} CDC vaccine database had uncovered a attainable security situation in which individuals 65 and older have been more prone to have an ischemic stroke 21 days after receiving the Pfizer/BioNTech bivalent shot, in contrast with days 22-44.
In China, no simple solution to get Pfizer’s COVID drug Paxlovid
When Li’s 83-year-old father with diabetes began coughing and complaining of physique aches final month, the Beijing resident grew to become anxious about discovering a remedy for COVID-19 in case his guardian had caught the virus sweeping the town. He heard at the moment that Pfizer’s anti-viral drug Paxlovid was an efficient remedy, however sufferers might solely get it prescribed in the event that they have been admitted to hospital, and provided that the drug was in inventory.
China, Hong Kong resume high-speed rail hyperlink after 3 years of COVID curbs
China resumed on Sunday high-speed rail providers between Hong Kong and the mainland for the primary time because the starting of the COVID-19 pandemic, because it dismantles journey curbs after Beijing scrapped quarantine for arrivals every week earlier. The re-opening comes amidst a large wave of infections nationwide and a day after authorities stated practically 60,000 individuals with COVID had died in hospital, following final month’s abrupt U-turn on “zero-COVID” coverage in the wake of historic protests.
(With inputs from companies.)

Recommended For You